Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1α accumulation in RAW264.7

Shock

Volumn 32, Issue 3, 2009, Pages 263-269

  Liu, Yi Nan ^a   Pan, Shiow Lin ^a   Liao, Cho Hwa ^a   Huang, Der Yi ^a   Guh, Jih Hwa ^a   Peng, Chieh Yu ^a   Chang, Ya Ling ^a   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Macrophage; p70S6K; Translation

Indexed keywords

CAMPTOTHECIN; CYCLOOXYGENASE 2; EVODIAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INITIATION FACTOR 4E BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; HYPOXIA; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSLATION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CAMPTOTHECIN; CELL HYPOXIA; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLIDINES; QUINAZOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; THIOCARBAMATES;

EID: 69549129495     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31819940cb     Document Type: Article

References (37)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126, 1999.
2. Bjornheden T, Levin M, Evaldsson M, Wiklund O: Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 19:870-876, 1999. (Pubitemid 29177331)
3. Murdoch C, Giannoudis A, Lewis CE: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224-2234, 2004. (Pubitemid 39331817)
4. Murdoch C, Muthana M, Lewis CE: Hypoxia regulates macrophage functions in inflammation. J Immunol 175:6257-6263, 2005. (Pubitemid 41598863)
5. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L, Lewis CE: Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163:1233-1243, 2003. (Pubitemid 37175073)
6. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE: Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66:889-900, 1999. (Pubitemid 30010512)
7. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al.: HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645-657, 2003. (Pubitemid 36331777)
8. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275, 1999.
9. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A: Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18:4691-4697, 2007. (Pubitemid 350246672)
10. Blouin CC, Page EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 103:1124-1130, 2004.
11. Semenza GL: Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345-350, 2001. (Pubitemid 32735019)
12. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732, 2003.
13. Bilton RL, Booker GW: The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur J Biochem 270:791-798, 2003.
14. Keiper BD, Gan W, Rhoads RE: Protein synthesis initiation factor 4G. Int J Biochem Cell Biol 31:37-41, 1999.
15. Keiper BD, Rhoads RE: Translational recruitment of Xenopus maternal mRNAs in response to poly(A) elongation requires initiation factor eIF4G-1. Dev Biol 206:1-14, 1999.
16. Khaleghpour K, Pyronnet S, Gingras AC, Sonenberg N: Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol 19:4302-4310, 1999. (Pubitemid 29242005)
17. Pullen N, Thomas G: The modular phosphorylation and activation of p70s6k. FEBS Lett 410:78-82, 1997.
18. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N: Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13:1422-1437, 1999. (Pubitemid 29270247)
19. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E: Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277:27975-27981, 2002. (Pubitemid 34966746)
20. Ko HC, Wang YH, Liou KT, Chen CM, Chen CH, Wang WY, Chang S, Hou YC, Chen KT, Chen CF, et al.: Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 555:211-217, 2007. (Pubitemid 46048800)
21. Chiou WF, Sung YJ, Liao JF, Shum AY, Chen CF: Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod 60:708-711, 1997. (Pubitemid 27318419)
22. Ogasawara M, Matsubara T, Suzuki H: Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol Pharm Bull 24:917-920, 2001. (Pubitemid 32750318)
23. Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist 9(Suppl 5):10-17, 2004. (Pubitemid 39658341)
24. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182:1683-1693, 1995.
25. Takada Y, Kobayashi Y, Aggarwal BB: Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280:17203-17212, 2005. (Pubitemid 41389187)
26. Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM: YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26:3941-3951, 2007.
27. Zhou J, Schmid T, Frank R, Brune B: PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J Biol Chem 279:13506-13513, 2004. (Pubitemid 38468875)
28. Zhou J, Schmid T, Brune B: Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell 14:2216-2225, 2003. (Pubitemid 36724315)
29. Ke Q, Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469-1480, 2006.
30. Hur E, Chang KY, Lee E, Lee SK, Park H: Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol Pharmacol 59:1216-1224, 2001. (Pubitemid 32381601)
31. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J: p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637, 1999. (Pubitemid 129535289)
32. Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE: EPAS1 transactivation during hypoxia requires p42/p44 MAPK. J Biol Chem 274:33709-33713, 1999. (Pubitemid 129511686)
33. Agani F, Semenza GL: Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol Pharmacol 54:749-754, 1998. (Pubitemid 28523166)
34. Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H: Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 31:673-682, 2007. (Pubitemid 46560001)
35. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL: Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211, 2002. (Pubitemid 35154674)
36. Hay N, Sonenberg N: Upstream and downstream of mTOR. Genes Dev 18:1926-1945, 2004.
37. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545, 2000. (Pubitemid 30183422)